BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 12458353)

  • 1. Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment.
    Gillissen A; Höffken G
    Med Microbiol Immunol; 2002 Dec; 191(3-4):165-8. PubMed ID: 12458353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].
    de Jong JC; Beyer WE; Rimmelzwaan GF; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):73-9. PubMed ID: 14753128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuraminidase inhibitors: progress in the management of influenza.
    Woodhead M; Lavanchy D; Johnston S; Colman P; Fleming D
    Int J Clin Pract; 2000 Nov; 54(9):604-10. PubMed ID: 11220989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated treatment for influenza A and B.
    Montalto NJ; Gum KD; Ashley JV
    Am Fam Physician; 2000 Dec; 62(11):2467-76. PubMed ID: 11130232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuraminidase inhibitors in therapy of influenza].
    Fladerer P; Wenisch C
    Acta Med Austriaca; 2000; 27(5):133-40. PubMed ID: 11261262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
    Vogel GE
    Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuraminidase inhibitors in prophylaxis and treatment of influenza].
    Nitsch-Osuch A; Brydak LB; Wardyn AK
    Pol Merkur Lekarski; 2008 Jul; 25(145):67-73. PubMed ID: 18839619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oseltamivir for influenza.
    Drug Ther Bull; 2002 Dec; 40(12):89-91. PubMed ID: 12613182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A multicenter study of efficacy and safety of oseltamivir in the treatment of suspected influenza patients].
    Deng WW; Li QY; Zhong NS;
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2132-6. PubMed ID: 15730636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population].
    Lin JT; Yu XZ; Cui DJ; Chen XY; Zhu JH; Wang YZ; Wu XD; Gao H; Huo ZL; Zhu SH; Hu SL; Wang AX
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):455-9. PubMed ID: 15312558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral management of seasonal and pandemic influenza.
    Hayden FG; Pavia AT
    J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral oseltamivir in human experimental influenza B infection.
    Hayden FG; Jennings L; Robson R; Schiff G; Jackson H; Rana B; McClelland G; Ipe D; Roberts N; Ward P
    Antivir Ther; 2000 Sep; 5(3):205-13. PubMed ID: 11075941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza.
    McCullers JA
    J Infect Dis; 2004 Aug; 190(3):519-26. PubMed ID: 15243927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza virus susceptibility and resistance to oseltamivir.
    Aoki FY; Boivin G; Roberts N
    Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
    Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE;
    J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.
    Kawai N; Ikematsu H; Iwaki N; Satoh I; Kawashima T; Maeda T; Miyachi K; Hirotsu N; Shigematsu T; Kashiwagi S
    Clin Infect Dis; 2005 May; 40(9):1309-16. PubMed ID: 15825034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A designer drug against influenza: the NA inhibitor oseltamivir (Tamiflu).
    Oxford JS; Mann A; Lambkin R
    Expert Rev Anti Infect Ther; 2003 Aug; 1(2):337-42. PubMed ID: 15482128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Highly selective virostatic therapy. Influenza wave could have been stopped].
    Leshel-Hauzeneder M
    MMW Fortschr Med; 2003 Mar; 145(13):54-5. PubMed ID: 15101538
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of the neuraminidase inhibitor oseltamivir for the management of seasonal influenza].
    Ruf BR; Sandow P; Lehmann P; Del Piero L; Skopnik H
    Dtsch Med Wochenschr; 2008 Jun; 133(23):1259-64. PubMed ID: 18509804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.